# Immunovant, Inc.: Form DEF 14A, filed Jun 26, 2023

- Company: [Immunovant, Inc.](/companies/imvt.md) (CIK 1764013)
- Form: DEF 14A
- Filed: 2023-06-26
- Accepted by EDGAR: Jun 26, 2023, 07:26 ET
- Period: 2023-08-21
- Accession: 0001764013-23-000072
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1764013/000176401323000072/imvt-20230331defproxy.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1764013/000176401323000072/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1764013/000176401323000072/imvt-20230331defproxy.htm

Filed Jun 26, 2023.
Source: SEC EDGAR, the filing index for accession 0001764013-23-000072. Last ingested by Listed: Nov 13, 2026, 16:26 ET. No prices; not investment advice.
